Syndax Pharmaceuticals Stock Return On Equity
SNDX Stock | USD 20.28 0.17 0.85% |
Syndax Pharmaceuticals fundamentals help investors to digest information that contributes to Syndax Pharmaceuticals' financial success or failures. It also enables traders to predict the movement of Syndax Stock. The fundamental analysis module provides a way to measure Syndax Pharmaceuticals' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Syndax Pharmaceuticals stock.
Last Reported | Projected for Next Year | ||
Return On Equity | (0.38) | (0.40) |
Syndax | Return On Equity |
Syndax Pharmaceuticals Company Return On Equity Analysis
Syndax Pharmaceuticals' Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current Syndax Pharmaceuticals Return On Equity | -0.52 |
Most of Syndax Pharmaceuticals' fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Syndax Pharmaceuticals is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Syndax Return On Equity Driver Correlations
Understanding the fundamental principles of building solid financial models for Syndax Pharmaceuticals is extremely important. It helps to project a fair market value of Syndax Stock properly, considering its historical fundamentals such as Return On Equity. Since Syndax Pharmaceuticals' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Syndax Pharmaceuticals' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Syndax Pharmaceuticals' interrelated accounts and indicators.
Click cells to compare fundamentals
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
Competition |
Syndax Total Stockholder Equity
Total Stockholder Equity |
|
Based on the latest financial disclosure, Syndax Pharmaceuticals has a Return On Equity of -0.519. This is 97.83% lower than that of the Biotechnology sector and 98.58% lower than that of the Health Care industry. The return on equity for all United States stocks is 67.42% higher than that of the company.
Syndax Return On Equity Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Syndax Pharmaceuticals' direct or indirect competition against its Return On Equity to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Syndax Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Syndax Pharmaceuticals by comparing valuation metrics of similar companies.Syndax Pharmaceuticals is currently under evaluation in return on equity category among related companies.
Syndax Pharmaceuticals Current Valuation Drivers
We derive many important indicators used in calculating different scores of Syndax Pharmaceuticals from analyzing Syndax Pharmaceuticals' financial statements. These drivers represent accounts that assess Syndax Pharmaceuticals' ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Syndax Pharmaceuticals' important valuation drivers and their relationship over time.
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Market Cap | 267.7M | 918.7M | 1.1B | 1.5B | 1.5B | 1.6B | |
Enterprise Value | 244.0M | 824.0M | 938.7M | 1.5B | 1.2B | 1.3B |
Syndax Pharmaceuticals ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Syndax Pharmaceuticals' sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Syndax Pharmaceuticals' managers, analysts, and investors.Environmental | Governance | Social |
Syndax Fundamentals
Return On Equity | -0.52 | ||||
Return On Asset | -0.33 | ||||
Current Valuation | 1.28 B | ||||
Shares Outstanding | 84.99 M | ||||
Shares Owned By Insiders | 0.82 % | ||||
Shares Owned By Institutions | 99.18 % | ||||
Number Of Shares Shorted | 10.03 M | ||||
Price To Earning | 126.11 X | ||||
Price To Book | 3.33 X | ||||
Price To Sales | 12.67 X | ||||
Gross Profit | 139.71 M | ||||
EBITDA | (229.94 M) | ||||
Net Income | (209.36 M) | ||||
Cash And Equivalents | 350.71 M | ||||
Cash Per Share | 5.82 X | ||||
Total Debt | 1.64 M | ||||
Debt To Equity | 0 % | ||||
Current Ratio | 17.19 X | ||||
Book Value Per Share | 5.79 X | ||||
Cash Flow From Operations | (160.6 M) | ||||
Short Ratio | 10.71 X | ||||
Earnings Per Share | (3.24) X | ||||
Target Price | 34.18 | ||||
Number Of Employees | 184 | ||||
Beta | 1.01 | ||||
Market Capitalization | 1.71 B | ||||
Total Asset | 612.88 M | ||||
Retained Earnings | (902.4 M) | ||||
Working Capital | 522.78 M | ||||
Current Asset | 79.72 M | ||||
Current Liabilities | 13.32 M | ||||
Net Asset | 612.88 M |
About Syndax Pharmaceuticals Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Syndax Pharmaceuticals's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Syndax Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Syndax Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Syndax Pharmaceuticals offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Syndax Pharmaceuticals' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Syndax Pharmaceuticals Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Syndax Pharmaceuticals Stock:Check out Syndax Pharmaceuticals Piotroski F Score and Syndax Pharmaceuticals Altman Z Score analysis. For more information on how to buy Syndax Stock please use our How to Invest in Syndax Pharmaceuticals guide.Note that the Syndax Pharmaceuticals information on this page should be used as a complementary analysis to other Syndax Pharmaceuticals' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Complementary Tools for Syndax Stock analysis
When running Syndax Pharmaceuticals' price analysis, check to measure Syndax Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Syndax Pharmaceuticals is operating at the current time. Most of Syndax Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Syndax Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Syndax Pharmaceuticals' price. Additionally, you may evaluate how the addition of Syndax Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
Transaction History View history of all your transactions and understand their impact on performance | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
Stocks Directory Find actively traded stocks across global markets | |
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum |
Is Syndax Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Syndax Pharmaceuticals. If investors know Syndax will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Syndax Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (3.24) | Revenue Per Share 2.173 | Quarterly Revenue Growth 332.974 | Return On Assets (0.33) | Return On Equity (0.52) |
The market value of Syndax Pharmaceuticals is measured differently than its book value, which is the value of Syndax that is recorded on the company's balance sheet. Investors also form their own opinion of Syndax Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Syndax Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Syndax Pharmaceuticals' market value can be influenced by many factors that don't directly affect Syndax Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Syndax Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Syndax Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Syndax Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.